4//SEC Filing
BAFFI ROBERT 4
Accession 0001140361-18-030008
CIK 0001048477other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 8:23 PM ET
Size
16.0 KB
Accession
0001140361-18-030008
Insider Transaction Report
Form 4
BAFFI ROBERT
SVP, Technial Operations
Transactions
- Sale
Common Stock
2018-06-22$99.00/sh−6,621$655,479→ 83,604 total - Exercise/Conversion
Stock Option (Right to buy Common Stock)
2018-06-22−6,949→ 0 totalExercise: $14.39From: 2009-11-12Exp: 2019-05-11→ Common Stock (6,949 underlying) - Sale
Common Stock
2018-06-22$99.01/sh−328$32,475→ 83,276 total - Exercise/Conversion
Common Stock
2018-06-22$14.39/sh+6,949$99,996→ 90,225 total
Holdings
- 77,055(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Trade made pursuant to a 10b5-1 plan executed on March 6, 2018.
- [F2]Reflects the number of options outstanding after the transactions from this specific stock option grant.
Documents
Issuer
BIOMARIN PHARMACEUTICAL INC
CIK 0001048477
Entity typeother
Related Parties
1- filerCIK 0001274826
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 8:23 PM ET
- Size
- 16.0 KB